Cargando…

Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study

The mechanisms underlying neuropathic pain remain unclear. Lysophosphatidic acid (LPA) is a bioactive phospholipid derived mainly from lysophosphatidylcholine (LPC) by extracellular autotaxin (ATX), and has attracted attention as a candidate biomarker of neuropathic pain. We aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edamura, Tatsuma, Sumitani, Masahiko, Hayakawa, Kentaro, Inoue, Reo, Abe, Hiroaki, Tsuchida, Rikuhei, Chikuda, Hirotaka, Ogata, Toru, Kurano, Makoto, Aoki, Junken, Yatomi, Yutaka, Uchida, Kanji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633889/ https://www.ncbi.nlm.nih.gov/pubmed/36205847 http://dx.doi.org/10.1007/s40122-022-00445-2

Ejemplares similares

Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018)

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
por: Uranbileg, Baasanjav, et al.
Publicado: (2019)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Autotaxin and lysophosphatidic acid(1 )receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine
por: Nagai, Jun, et al.
Publicado: (2010)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Serum levels of apolipoprotein A-I and E are associated with postoperative delirium: A post hoc analysis
por: Mietani, Kazuhito, et al.
Publicado: (2022)

Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review
por: Tsuchida, Rikuhei, et al.
Publicado: (2020)

A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε)
por: Tokuhara, Yasunori, et al.
Publicado: (2015)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023)

Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study
por: Tsuchida, Rikuhei, et al.
Publicado: (2023)

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
por: Umezu-Goto, Makiko, et al.
Publicado: (2002)

Elevated neuron-specific enolase level is associated with postoperative delirium and detection of phosphorylated neurofilament heavy subunit: A prospective observational study
por: Mietani, Kazuhito, et al.
Publicado: (2021)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
por: Shin, Eunah, et al.
Publicado: (2019)

MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019)

Urine autotaxin levels reflect the disease activity of sarcoidosis
por: Murakami, Koji, et al.
Publicado: (2022)

Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells
por: Liu, Yang, et al.
Publicado: (2022)

Relationship between Neuropathic Pain and Obesity
por: Hozumi, Jun, et al.
Publicado: (2016)

Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome
por: Igarashi, Nozomi, et al.
Publicado: (2020)

Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Keune, Willem-Jan, et al.
Publicado: (2016)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
por: Yun, C. Chris
Publicado: (2019)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan: A Preliminary Study
por: Azuma, Kenji, et al.
Publicado: (2020)

Characteristics of Locomotive Syndrome in Japanese Patients with Chronic Pain and Results of a Path Analysis Confirming the Relevance of a Vicious Cycle Involving Locomotive Syndrome, Musculoskeletal Pain, and Its Psychological Factors
por: Ushio, Michiko, et al.
Publicado: (2019)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts
por: David, Marion, et al.
Publicado: (2010)

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
por: Clair, Timothy, et al.
Publicado: (2005)

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)

Expression of Autotaxin–Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2019)

Evaluation of Serum Lysophosphatidic Acid and Lysophosphatidylcholine Levels in Major Depressive Disorder Patients
por: Riya, Sumaia, et al.
Publicado: (2020)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Crosstalk between transforming growth factor β-2 and Autotaxin in trabecular meshwork and different subtypes of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cuf0v0jp8rus9lbgds43pk456j